TNFRSF10B and hepatocellular carcinoma: Collectively, these results present in vitro as well as in vivo evidence supporting the anti-HCC efficacy of WA and show the involvement of ERK as an important mediator for WA-induced RSK/ELK1 activation and DR5 upregulation.